A carregar...
CAR T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Immunotherapy with T cells genetically modified to express chimeric antigen receptors (CARs) that target tumor-associated molecules have impressive efficacy in hematological malignancies. The field has now embraced the challenge of applying this approach to treat common epithelial malignancies, whic...
Na minha lista:
| Publicado no: | J Immunol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5957501/ https://ncbi.nlm.nih.gov/pubmed/29311388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701155 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|